Depakene (Valproic Acid Liquid) and Tofacitinib Extended-Release Tablets
Determining the interaction of Depakene (Valproic Acid Liquid) and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: valproic acid
Brand name: Depakene, Depacon, Stavzor, Valproate Sodium
Synonyms: Depakene
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Depakene (Valproic Acid Liquid)-Tofacitinib Tablets
- Depakene (Valproic Acid Liquid)-Tofranil
- Depakene (Valproic Acid Liquid)-Tofranil injection
- Depakene (Valproic Acid Liquid)-Tofranil-PM
- Depakene (Valproic Acid Liquid)-Tol-Tab
- Depakene (Valproic Acid Liquid)-Tolazamide
- Tofacitinib Extended-Release Tablets-Depakote
- Tofacitinib Extended-Release Tablets-Depakote (Divalproex Long-Acting Tablets)
- Tofacitinib Extended-Release Tablets-Depakote (Divalproex Sprinkle Capsules)
- Tofacitinib Extended-Release Tablets-Depakote Capsules
- Tofacitinib Extended-Release Tablets-Depakote DR
- Tofacitinib Extended-Release Tablets-Depakote ER